Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (CFS)
BASICS
Description
- Chronic, complex illness with new/prolonged, debilitating fatigue (>6 months, moderate/severe at least half the time)
- Marked reduction in activity, not explained by another medical condition
- Key features: impaired memory/concentration, joint/muscle pain, nonrestorative sleep, postexertional malaise (PEM), orthostatic intolerance
- Synonyms: myalgic encephalomyelitis (ME), postviral fatigue syndrome, chronic Epstein-Barr virus syndrome, chronic fatigue immune dysfunction, systemic exertion intolerance disease
EPIDEMIOLOGY
- All ages; peaks: 10–19 & 30–39 years
- Females 2× as likely
- Prevalence: 519–1,038/100,000; 1.7–3.4 million U.S. cases
- Up to 90% undiagnosed
ETIOLOGY & PATHOPHYSIOLOGY
- Cause unknown, likely multifactorial
- Suspected stressors: viral/bacterial/parasitic infection (e.g., EBV, Lyme, HHV6), recent vaccination, overexertion, sleep deprivation, toxins, trauma, adverse medication reaction
- Contributing factors:
- Cellular metabolism: ↓ oxidative phosphorylation/mitochondrial function (T cells)
- Neuroendocrine: ↓ cortisol response
- Immune: ↑ cytokines, CRP, β2-microglobulin
- Muscular: ↓ oxygen uptake
- Autonomic: orthostatic hypotension
- Serotonergic: upregulated serotonin receptors
- GI: ↑ permeability, altered microbiota, IBS
- Genetics: higher concordance in monozygotic twins; polymorphisms in neuroimmunoendocrine genes
RISK FACTORS
- Family history
- Personality: neuroticism, introversion
- Comorbidities: depression, anxiety, childhood trauma, inactivity/overactivity, long-standing medical/mental health issues
- Prolonged idiopathic chronic fatigue
ASSOCIATED CONDITIONS
- Fibromyalgia, IBS, pelvic pain, endometriosis, gynecologic surgery
- Anxiety, depression, PTSD, ADHD
- POTS, OSA, migraines, TMJ, interstitial cystitis, Hashimoto, Raynaud, allergies
- Multiple chemical sensitivities, myofascial pain, reduced LV size/mass, mitral valve prolapse
DIAGNOSIS
History
- IOM 2015 Criteria:
- Substantial reduction in activity ≥6 months with profound, new fatigue not alleviated by rest
- PEM: worsening after exertion
- Nonrestorative sleep
- At least one: cognitive impairment or orthostatic intolerance
Physical Exam
- Rule out other causes (medical, mental status)
Differential Diagnosis
- Idiopathic chronic fatigue, depression, anxiety, substance use
- Poor sleep hygiene, pregnancy, menopause
- Sleep, endocrine, chronic/acute infection, medication, toxin, rheumatologic, inflammatory, neurologic, cardiovascular, malignancy
Diagnostic Tests
- No specific test; screen to exclude other causes
- Initial labs: CBC, CMP, UA, TSH, free T4, ESR/CRP, Mg, Phos, B12, folate, CK, Vit D, iron studies
- Follow-up: ANA, RF, TST, salivary cortisol, HIV, RPR, Lyme, TTG IgA, drug screen, age/gender-appropriate cancer screening, EEG/MRI (if CNS symptoms), polysomnography (if sleep disorder suspected)
TREATMENT
General Measures
- Symptom control and guided self-management
- Address most troublesome symptoms (pain, insomnia)
- CBT: not curative, but may improve coping/rehab
- GET: gradual increase, only with trained professional; pacing to manage PEM
- Multidisciplinary approach
Medication
- No established drugs for CFS
- Symptom-based: nonaddicting sleep aids (hydroxyzine, trazodone, doxepin); agomelatine promising; antivirals, antidepressants, immunoglobulins, steroids, modafinil, methylphenidate, gabapentin, galantamine—no clear benefit
- Use lowest effective dose
Referral
- Psychiatry (behavioral), rehabilitation, sleep/pain specialists
Complementary & Alternative
- Acupuncture, massage, chiropractic, PT, stretching, hydrotherapy, yoga, tai chi, qigong, meditation
- Hot/cold packs, warm baths, electrical massagers, TENS
- Homeopathy/biofeedback: equivocal evidence
ONGOING CARE
Monitoring
- No consensus; periodic reevaluation/support
- Diet: no evidence for any particular diet
Patient Education
- Gradually increase exercise tolerance
- Explain PEM/energy envelope; teach “paced” activity
- Avoid extended rest, but ensure adequate breaks
- CBT, lifestyle, pharmacologic options
- Educate family, support disability applications
- Patient resources: Solve ME/CFS, CDC ME/CFS
PROGNOSIS
- Severity: mild, moderate, severe, very severe
- Fluctuating course, relapses common, improvement slow (months–years)
- <1/3 return to work; 25% bedridden/housebound
COMPLICATIONS
- Activity reduction, depression, polypharmacy
- Unemployment/secondary gain
- ↑ Non-Hodgkin lymphoma risk in elderly with chronic immune activation
ICD-10
- R53.82: Chronic fatigue, unspecified
Clinical Pearls
- IOM criteria for diagnosis
- True CFS is less common than idiopathic chronic fatigue
- No pharmacologic agent consistently effective
- Management: symptom relief, QoL, patient support, needs assessment